Phio Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11 Apex Dr Ste 300A, Marlborough, Massac...Phone Number
(508) 767-3861Website
www.phiopharma.comRevenue
-Stock Symbol
PHIOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Phio Pharmaceuticals
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phios Pharmaceuticals in 2018. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics.Explore more
Phio Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phio Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Phio Pharmaceuticals
Earning: See what the market has to say on Phio Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Phio Pharmaceuticals launches new products
Check if Phio Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Phio Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Phio Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Phio Pharmaceuticals has new funding data
Click to see if Phio Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Phio Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Phio Pharmaceuticals
Compare insights from companies similar to Phio Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Phio Pharmaceuticals
1-10
Public
$24.6M
2011
MS
Mark SchwartzExecutive Vice President & Chief Operating Officer
<$5M
11-50
Private
$81.2M
2008
MP
Marilena PerroneResearch & Development Operations Manager, Project Management
Company Profile Activity
Activity Insights
Phio Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phio Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phio Pharmaceuticals.
Phio Pharmaceuticals financials insights
Gather financial insights about Phio Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$10.4M
2020
Debt
$150K
2021
Share Placement
$14M
Phio Pharmaceuticals Tech Stack
A closer look at the technologies used by Phio Pharmaceuticals
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Promotion
Executive Move
Executive Moves, Promotion
Project
Phio Pharmaceuticals is laser-focused on advancing PH-762 to its next development stage, recognizing that with limited personnel and funding, the company must carefully manage its resources to complete projects successfully.
Asset Management, Financial Planning, Pharmaceuticals, Corporate Strategy, Finance, Financial Strategy
Pain Point
experienced a nine-month delay with a large pharmaceutical partner who ultimately decided not to pursue a collaboration after the lead person on the program retired and the remaining team lost interest in the project. This experience highlighted the challenges of working with large pharma organizations where process complexity and uncontrollable variables can prevent energized outcomes.
Partnership, Business Development, Pharmaceuticals, Change Management
Project
Compliance, Governmental Affairs & Regulation, Pharmaceuticals, Clinical Operations, Regulations
Phio Pharmaceuticals News & Media
Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy for skin cancers COSTA MESA, CA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Pyramid Pharma Services, a U.S.-based contract …Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
A Critical Next Step in Advancing Phio’s PH-762 Program to Treat Cutaneous Carcinomas Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a …Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.comPhio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
Phase 1b Trial Reported Approximately 65% Pathological Response in cSCC, Including Complete Responses at Maximum Dose, With No Serious Adverse Events Phio Pharmaceuticals Corp. (NASDAQ:PHIO) NEW YORK, NY, UNITED STATES, February 23, 2026 /EINPresswire. …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phio Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phios Pharmaceuticals in 2018. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics.... Read More
